Why the study?
Does isoproterenol and glucagon infusion reveal hyperresponsiveness of beta-adrenergic receptors in patients with hyperkinetic borderline essential hypertension compared to controls?
Does isoproterenol and glucagon infusion reveal hyperresponsiveness of beta-adrenergic receptors in patients with hyperkinetic borderline essential hypertension compared to controls?
Patients with hyperkinetic borderline essential hypertension exhibit hyperreactivity of beta-adrenergic receptors or adenylate cyclase, as evidenced by exaggerated cAMP and heart rate responses to isoproterenol.
No takes yet. Share an insight, caveat, or question.
May support beta-adrenergic hyperresponsiveness in hyperkinetic BEH; hypothesis-generating and should not yet change practice.
Messerli et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: